January 30, 2019 — Magnetic resonance imaging (MRI) provides a safe, noninvasive way to monitor liver fat levels in people who undergo weight loss treatments for obesity, according to a new study published in the journal Radiology.1

January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission ultrasound technology known as the QTscan. The U.S. Food and Drug Administration (FDA)-cleared 3-D ultrasound breast imaging technology provides women an option with no radiation, no compression and no injections.

ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell imaging agent. The trial will enroll metastatic cancer patients and will study the correlation of imaging signals observed using ImaginAb’s CD8+ T cell ImmunoPET imaging agent, standard-of-care scans and immunohistochemistry analysis of CD8 in biopsied tissues.

The odds are good that radiologists want to believe in artificial intelligence (AI). The hype from vendors, professional societies and the media has been pointing them in that direction for the last couple years. Unfortunately, if history is a guide, there is a good chance that medical AI will fall short. This must not happen. The potential benefit of AI is too great for it to fail again.

Traditional mammography continues to be the gold standard for breast cancer screening technologies. However, use of 3-D breast tomosynthesis is growing rapidly.
Breast Imaging Sectra

The importance of early detection of breast cancer has been underscored in recent years as the breast health community learns more about breast density and risk models, turning toward personalized medicine. As this knowledge base expands, healthcare professionals are exploring the benefits of different imaging technologies to improve detection and save lives.

 

Mammography

January 30, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic resonance imaging (MRI) scanner from Siemens Healthineers.

Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes
Beaumont Hospital Cancer Institute performed the first Irradiation of spot scanning proton arc therapy plan.

Artificial intelligence (AI) has been the hot topic discussed at all trade shows, and the 2018 American Society for Radiation Oncology (ASTRO) annual meeting was no exception.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now